Skip to main content
Premium Trial:

Request an Annual Quote

Meridian Bioscience Gets CE Mark for CT/NG Tests, Sample Prep System

NEW YORK (GenomeWeb) – Meridian Bioscience said today that it has received the CE mark for two new Illumigene molecular diagnostic tests for Chlamydia trachomatis and Neisseria gonorrhoeae.

The new tests are the sixth and seventh on the Illumigene platform, which is based on loop-mediated isothermal amplification. Illumigene CT and NG use endocervical swabs, self-collected vaginal swabs, and female and male urine, making collection easy and non-invasive, Meridian said. The tests take less than one hour to perform, and require no expensive capital equipment, the company also noted.

Illumigene also said that it received the CE mark for M-prep, a sample preparation system designed to facilitate the isolation of C. trachomatis and N. gonorrhoeae from clinical samples.

All three new products will be distributed in Europe, the Middle East, and Africa by Meridian Bioscience Europe and in additional international markets through distributors.

The Scan

Less Than Half

An effort to reproduce key findings from high-profile preclinical cancer studies finds less than half could be replicated, according to the Scientist.

Still Some SARS-CoV-2 Sequencing Holes

The Wall Street Journal reports that viral genomic surveillance has improved in the US, though says there are still gaps.

Avoiding Passing Them On

People with known disease-linked genetic variants are turning to in vitro fertilization so as to not pass those variants to their children, the Washington Post says.

PNAS Papers on Long Cell-Free DNA in Maternal Plasma, Genetic Propensity for Voting

In PNAS this week: long, cell-free DNA of maternal and fetal origins identified in maternal plasma, and more.